{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:07Z","timestamp":1761102247241},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jval.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T08:31:45Z","timestamp":1482222705000},"page":"512-515","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treacle and Smallpox: Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment"],"prefix":"10.1016","volume":"20","author":[{"given":"Alec","family":"Morton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2016.10.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple criteria decision analysis for health care decision making\u2014an introduction: report 1 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.10.005_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple criteria decision analysis for health care decision making\u2014emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.10.005_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40273-014-0135-0","article-title":"Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature","volume":"32","author":"Marsh","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2016.10.005_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.15171\/ijhpm.2016.83","article-title":"Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness","volume":"5","author":"Baltussen","year":"2016","journal-title":"Int J Health Policy Manag"},{"key":"10.1016\/j.jval.2016.10.005_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B","article-title":"Intergenerational equity: an exploration of the \u201cfair innings\u201d argument","volume":"6","author":"Williams","year":"1997","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2016.10.005_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hec.3019","article-title":"Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis","volume":"24","author":"Verguet","year":"2015","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2016.10.005_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1473-3099(15)00500-9","article-title":"Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach","volume":"16","author":"Rex","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jval.2016.10.005_bib8","unstructured":"Scottish Medicines Consortium. SMC modifiers used in appraising new medicines. Available from: http:\/\/www.scottishmedicines.org.uk\/About_SMC\/Policy_statements\/SMC_Modifiers_used_in_Appraising_New_Medicines. [Accessed September 26, 2016]."},{"key":"10.1016\/j.jval.2016.10.005_bib9","first-page":"22","article-title":"Why has value based assessment been abandoned by NICE in the UK?","volume":"1","author":"Kusel","year":"2015","journal-title":"Value Outcomes Spotlight"},{"key":"10.1016\/j.jval.2016.10.005_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10198-011-0346-7","article-title":"Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall","volume":"14","author":"van de Wetering","year":"2013","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2016.10.005_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2125.2004.02147.x","article-title":"Venetian treacle and the foundation of medicines regulation","volume":"58","author":"Griffin","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jval.2016.10.005_bib12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jval.2013.10.002","article-title":"A pilot study of multicriteria decision analysis for valuing orphan medicines","volume":"16","author":"Sussex","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.10.005_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/0272989X11416870","article-title":"Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA) applying the EVIDEM framework to medicines appraisal","volume":"32","author":"Goetghebeur","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2016.10.005_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1478-7547-4-14","article-title":"Priority setting of health interventions: the need for multi-criteria decision analysis","volume":"4","author":"Baltussen","year":"2006","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.jval.2016.10.005_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-7547-4-3","article-title":"Developing a prioritisation framework in an English primary care trust","volume":"4","author":"Wilson","year":"2006","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.jval.2016.10.005_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1057\/palgrave.jors.2602550","article-title":"Behavioural decision theory for multi-criteria decision analysis: a guided tour","volume":"60","author":"Morton","year":"2009","journal-title":"J Oper Res Soc"},{"key":"10.1016\/j.jval.2016.10.005_bib17","series-title":"Decisions with Multiple Objectives: Preferences and Value Tradeoffs","author":"Keeney","year":"1976"},{"key":"10.1016\/j.jval.2016.10.005_bib18","series-title":"Multiple Criteria Decision Analysis: An Integrated Approach","author":"Belton","year":"2002"},{"key":"10.1016\/j.jval.2016.10.005_bib19","first-page":"18","article-title":"ISafE and the evidence-based approach for essential medicines selection in Thailand","volume":"34","author":"Chongtrakul","year":"2005","journal-title":"Essent Drugs Monit"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516340529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516340529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T19:24:26Z","timestamp":1536175466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301516340529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1098301516340529"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2016.10.005","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treacle and Smallpox: Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}